27 June 2016 in Scientific Reports
VSVenkatesan Saravanakumar
+4
Nitric oxide (NO), a vascular signaling molecule, is primarily produced by endothelial NO synthase. Recently, a functional endothelial NO synthase (eNOS) was described in red blood cells (RBC). The RBC-eNOS contributes to the intravascular NO pool and regulates physiological functions. However the regulatory mechanisms and clinical implications of RBC-eNOS are unknown. The present study investigated regulation and functions of RBC-eNOS under mechanical stimulation. This study shows that mechanical stimuli perturb RBC membrane, which triggers a signaling cascade to activate the eNOS. Extracellular NO level, estimated by the 4-Amino-5-Methylamino-2′, 7′-Difluorofluorescein Diacetate probe, was significantly increased under mechanical stimuli. Immunostaining and western blot studies confirmed that the mechanical stimuli phosphorylate the serine 1177 moiety of RBC-eNOS and activates the enzyme. The NO produced by activation of RBC-eNOS in vortexed RBCs promoted important endothelial functions such as migration and vascular sprouting. We also show that mechanical perturbation facilitates nitrosylation of RBC proteins via eNOS activation. The results of the study confirm that mechanical perturbations sensitize RBC-eNOS to produce NO, which ultimately defines physiological boundaries of RBC structure and functions. Therefore, we propose that mild physical perturbations before, after, or during storage can improve viability of RBCs in blood banks.
3 September 2015 in RSC Advances
TSThangarasu Silambarasan
Natural compounds can interact with multiple cellular target proteins and may be prioritized as drug leads. There is a need for prioritization of compounds that protect cardiovascular systems from pathological conditions. Here we prioritize morin, veratric acid, piperine, syringic acid, vanillic acid, diosgenin, diosmetin and sinapic acid that were already identified as cardioprotective molecules in our previous studies through multi-level data integration. In this study, initially we predict targets of the above-mentioned compounds by reverse pharmacophore (PharmMapper) and structural similarity based target-screening methods. We also explored the compound–target pathways (Biocarta and KEGG) and disease relationships. Further, we chose public microarray transcriptomic data from GEO to prioritize important pathogenic targets (heart failure, cardiac hypertrophy, vascular dysfunction and atherosclerosis), and we explored the interaction potential of the above compounds on the targets via blind docking (AutoDock Vina). Moreover, the multi target action of compounds was revealed by target information retrieved from large-scale text mining and organized databases (HIT and TCMID). The drug likeness profile and toxicity prediction was achieved based on Lipinski's rule and structural similarity search (ProTox). The observed results have demonstrated that the multi target potential and less toxic nature mean these molecules can be prioritized as lead compounds for cardiovascular diseases.
9 January 2020 in Eye and Vision
Background: Stargardt disease 1 (STGD1; MIM 248200) is a monogenic form of autosomal recessive genetic disease caused by mutation in ABCA4. This gene has a major role in hydrolyzing N-retinylidene-phosphatidylethanolamine to all-trans-retinal and phosphatidylethanolamine. The purpose of this study is to identify the frequency of putative disease-causing mutations associated with Stargardt disease in a South Indian population. Methods: A total of 28 clinically diagnosed Stargardt-like phenotype patients were recruited from south India. Ophthalmic examination of all patients was carefully carried out by a retina specialist based on the stages of fundus imaging and ERG grouping. Genetic analysis of ABCA4 was performed for all patients using Sanger sequencing and clinical exome sequencing. Results: This study identified disease-causing mutations in ABCA4 in 75% (21/28) of patients, 7% (2/28) exhibited benign variants and 18% (5/28) were negative for the disease-causing mutation. Conclusion: This is the first study describing the genetic association of ABCA4 disease-causing mutation in South Indian Stargardt 1 patients (STGD1). Our findings highlighted the presence of two novel missense mutations and an (in/del, single base pair deletion & splice variant) in ABCA4. However, genetic heterogeneity in ABCA4 mutants requires a larger sample size to establish a true correlation with clinical phenotype.
1 January 2018 in Journal of Clinical Neonatology
PGPrakadeeswari Gopalakrishnan
Prakadeeswari Gopalakrishnan
VPVijayalakshmi Perumalsamy
Vijayalakshmi Perumalsamy
Oculocutaneous albinism (OCA) is an autosomal recessive disorder, phenotypically subcategorized as OCA subtype 1A (OCA-1A) and OCA subtype 1B (OCA-1B). Both the subtypes are genetically caused by the mutations in the tyrosinase (TYR) gene. A 6-month-old nonidentical twin sister was albino who was diagnosed with OCA-1A and had clinical features including hypopigmentation in iris, lid, lashes, skin, nystagmus, and albinotic fundus. Genetic screening revealed the pathogenic mutation at TYR gene locus in albino child, whereas the other child was carrier and holding normal phenotype. We report a differential TYR expression pattern on one of the nonidentical twins.
30 January 2026 in Human Genomics
GKGovindasamy Kumaramanickavel
Govindasamy Kumaramanickavel
+1
Inherited retinal diseases (IRDs) are highly diverse and rare genetic disorders causing mild to complete vision loss across different age groups, with a no